Subgroup Could Give Xpovio Focused Commercial Opportunity In Endometrial Cancer

Digital illustration of Cancer cell in colour background
Karyopharm announced topline results from its Phase III SIENDO trial in endometrial cancer • Source: Shutterstock

More from Anticancer

More from Therapeutic Category